NIH Public Access: Author Manuscript
NIH Public Access: Author Manuscript
NIH Public Access: Author Manuscript
Author Manuscript
Am Psychol. Author manuscript; available in PMC 2009 December 11.
Published in final edited form as:
NIH-PA Author Manuscript
Benjamin B. Lahey
University of Chicago
Abstract
The personality trait of neuroticism refers to relatively stable tendencies to respond with negative
emotions to threat, frustration, or loss. Individuals in the population vary markedly on this trait,
ranging from frequent and intense emotional reactions to minor challenges to little emotional reaction
even in the face of significant difficulties. Although not widely appreciated, there is growing evidence
that neuroticism is a psychological trait of profound public health significance. Neuroticism is a
robust correlate and predictor of many different mental and physical disorders, comorbidity among
them, and the frequency of mental and general health service use. Indeed, neuroticism apparently is
NIH-PA Author Manuscript
a predictor of the quality and longevity of our lives. Achieving a full understanding of the nature and
origins of neuroticism, and the mechanisms through which neuroticism is linked to mental and
physical disorders, should be a top priority for research. Knowing why neuroticism predicts such a
wide variety of seemingly diverse outcomes should lead to improved understanding of commonalities
among those outcomes and improved strategies for preventing them.
Keywords
Neuroticism; personality traits; public health; predictive utility
Personality traits quantify the marked variations in typical responding to the environment that
distinguish one person from another (Mischel, 2004). Although personality traits have long
been a topic of interest to psychologists, many of us are not aware of their broad and
considerable importance to public health. The goal of this paper is to change that perception
for one particularly important personality trait. Neuroticism refers to individual differences in
negative emotional response to threat, frustration, or loss (Costa & McCrae, 1992a; Goldberg,
1993). Although the term neuroticism has its roots in Freudian theory, and the ancient
NIH-PA Author Manuscript
philosophical and medical traditions on which psychodynamic models were based, the modern
conception of neuroticism is unrelated to such theories of unconscious conflict. Rather
neuroticism is usually defined today in purely descriptive psychometric terms.
Publisher's Disclaimer: The following manuscript is the final accepted manuscript. It has not been subjected to the final copyediting,
fact-checking, and proofreading required for formal publication. It is not the definitive, publisher-authenticated version. The American
Psychological Association and its Council of Editors disclaim any responsibility or liabilities for errors or omissions of this manuscript
version, any version derived from this manuscript by NIH, or other third parties. The published version is available at
www.apa.org/journals/amp.
Lahey Page 2
often referred to as negative emotionality or negative affectivity, is included in nearly all major
models of personality traits (Matthews, Deary, & Whiteman, 2003), including three-factor
(Eysenck, 1947; Tellegen, 1982) and five-factor models (Costa & McCrae, 1992b; Goldberg,
NIH-PA Author Manuscript
Although the stability of neuroticism, in the sense of maintaining rank-order position relative
to other persons, increases with age from adolescence through adulthood (Roberts &
DelVecchio, 2000), mean neuroticism scores peak in late adolescence and decline moderately
through adulthood (Costa et al., 1986; McCrae et al., 2002; Roberts & Mroczek, 2008). Mean
neuroticism scores of females are slightly but significantly higher than for males (Costa,
Terracciano, & McCrae, 2001) and neuroticism scores tend to be somewhat higher among
individuals with lower socioeconomic status (Judge, Higgins, Thoresen, & Barrick, 1999).
Therefore, it is informative that most studies of the associations between neuroticism and
mental and physical health that controlled age, sex, and socioeconomic status have found that
neuroticism is associated with mental and physical health independent of its correlation with
these demographic factors (Kendler, Kuhn, & Prescott, 2004; Neeleman, Ormel, & Bijl,
2001; Stronks, van de Mheen, Looman, & Mackenbach, 1997).
Neuroticism can be viewed as a heterogeneous trait consisting of multiple facets that are highly
correlated but partially distinct, including anger, sadness, anxiety, worry, and hostility (Weiss
& Costa, 2005). Indeed, many studies of the relation between negative affectivity and adverse
NIH-PA Author Manuscript
outcomes focus on fine-grained traits that might be considered facets of neuroticism, such as
trait hostility and anger (T. W. Smith, Glazer, Ruiz, & Gallo, 2004; Suarez, Lewis, & Kuhn,
2002). The present paper focuses on the broad trait of neuroticism, but some facets of
neuroticism may be more important than others for specific purposes.
It should be emphasized that there is a lack of full independence between most measures of
neuroticism and measures of some mental health outcomes. In particular, the fact that some of
the items that define neuroticism in most scales overlap with symptoms of depression and
anxiety complicates the interpretation of correlations with these disorders (Jylha & Isometsa,
2006). In particular, in cross-sectional studies, it is possible that neuroticism and mental
disorders could be correlated because persons who are currently experiencing an episode of
depression or anxiety disorder might endorse more of these overlapping neuroticism items than
either before or after the episode. Nonetheless, the association between neuroticism and public
health outcomes is not merely an artifact of overlapping criteria. A number of longitudinal
studies have controlled for shared items and concurrent depressive states and still found
significant associations between the construct of neuroticism and measures of depression
(Fergusson, Horwood, & Lawton, 1989; Schmutte & Ryff, 1997; Spijker, de Graaf, Oldehinkel,
Nolen, & Ormel, 2007). In addition, as summarized in this paper, neuroticism is robustly linked
NIH-PA Author Manuscript
to many mental disorders (e.g., somatoform disorders, eating disorders, schizophrenia, and
substance use disorders) and to physical health problems that are not defined by symptoms that
overlap with neuroticism items. Indeed, there is some evidence that neuroticism may predict
a wide range of physical health problems even when depression is controlled (Bouhuys,
Flentge, Oldehinkel, & van den Berg, 2004; Russo, Katon, Lin, & Von Korff, 1997).
Nonetheless, greater attention to the issues of conceptual and criterion overlap in the
operational definitions of neuroticism and some mental disorders is needed in the future.
This paper overviews what is known about neuroticism, attempts to explain why it has great
significance for the public health, and summarizes working hypotheses to guide current
research on the causal links between neuroticism and mental and physical health problems.
Because funding for basic research from the National Institutes of Health is more closely tied
to the public health significance of the specific research aims than ever before, I argue that
neuroticism is an important topic for policy makers and researchers in both basic and applied
areas of psychology.
NIH-PA Author Manuscript
disorders was conducted based on 33 population-based samples (Malouff et al., 2005). Table
1 presents effect sizes for the strength of association with the mental disorder, expressed as d
(Cohen, 1988). A value of d = .50 would indicate that persons who met criteria for each mental
disorder had neuroticism scores that were one-half a standard deviation higher on average than
persons who did not meet criteria for the disorder. A value of d = 1.0 would indicate a one
standard deviation difference. Conventionally, effect sizes of d > .50 are considered to be
“medium” and effect sizes of d > .80 be considered to be “large” (Cohen, 1998). The meta-
analysis (Malouff et al., 2005) revealed that the magnitudes of association between neuroticism
and mood disorders, anxiety disorders, somatoform disorders, schizophrenia, and eating
disorders were all in the large range. Furthermore, studies conducted after this meta-analysis
have confirmed the robust associations between neuroticism and Axis I mental disorders
(Chien, Koa, & Wub, 2007; Khan et al., 2005; Weinstock, 2006). In particular, a study of 7,588
adult twins (Khan et al., 2005) found large effect sizes for the association between neuroticism
and depression, generalized anxiety disorder, and panic disorder, and medium effect sizes for
phobias, alcohol and drug dependence, and antisocial personality disorder. In addition,
neuroticism is robustly associated with dysthymia (Akiskal et al., 2006) and there is extensive
evidence that higher neuroticism is related to the use and abuse of psychoactive substances,
from nicotine and alcohol to heroin (Kornør & Nordvik, 2007; Malouff, Thorsteinsson, Rooke,
NIH-PA Author Manuscript
& Schutte, 2007; Malouff et al., 2006; Sher & Trull, 1994).
There also is extensive evidence that neuroticism is correlated with a number of Axis II
personality disorders (Clark et al., 1994; Costa & Widiger, 2002; Krueger & Markon, 2001;
Saulsman & Page, 2004; Sher & Trull, 1994). As shown in Table 2, a meta-analytic review of
this literature (Saulsman & Page, 2004) found medium effect sizes for associations between
neuroticism and borderline, avoidant, and dependent personality disorders, and smaller effect
sizes for schizotypal, paranoid, and antisocial personality disorder. It should be noted that a
number of modifications of the taxonomy of personality disorders in DSM-V have been
proposed that could make the definitions of personality disorders more consonant with either
three or five-factor models of personality that include the trait of neuroticism (McCrae,
Lockenhoff, & Costa, 2005; Widiger & Trull, 2007). Thus, neuroticism may be even more
strongly linked to future diagnostic definitions of personality disorders.
al., 2005; Middeldorp et al., 2006; Weinstock, 2006). Indeed, in one large study, variations in
neuroticism explained 20–45% of the comorbidity among depression and anxiety disorders
and 19–88% of the comorbidity of those disorders with alcohol dependence and drug
dependence (Khan et al., 2005). This is important because persons with comorbid mental
disorders have more persistent and disabling disorders, and are more likely to use high-cost
mental health services, than persons who meet criteria for only one mental disorder (Kessler,
Chiu, Demler, & Walters, 2005). Furthermore, higher neuroticism is associated with greater
use of mental health services even when the number of comorbid mental disorders is controlled
(Jylha & Isometsa, 2006; ten Have, Oldehinkel, Vollebergh, & Ormel, 2005). In addition,
persons with comorbid mental disorders have significantly poorer physical health and are more
likely to be high-end users of medical services (Rush et al., 2005). This means that neuroticism
is centrally important to public health partly because persons with high levels of neuroticism
are at high risk for having the most serious, impairing, and costly mental health problems. The
combined estimated 12-month prevalence of the many Axis I and II mental disorders shown
to be moderately to strongly correlated with neuroticism is upwards of 20% of the U.S.
population (Narrow, Rae, Robins, & Regier, 2002). Given the enormous personal distress and
impairment associated with these mental disorders and their overall impact on the economy
(Merikangas et al., 2007), the association of neuroticism with mental disorders is no small
NIH-PA Author Manuscript
matter.
The utility of neuroticism in predicting first episodes of major depression was evaluated in a
longitudinal study of 1,733 twins from female-female pairs and 1,862 twins from male-male
pairs (Fanous, Neale, Aggen, & Kendler, 2007; Kendler, Neale, Kessler, Heath, & Eaves,
1993). Excluding participants who had already experienced an episode of depression by the
NIH-PA Author Manuscript
time neuroticism was measured, each 1 standard deviation (SD) unit difference in higher
neuroticism scores was associated with a 90–100% increase in the odds of developing major
depression for the first time during the next 12 months in women (Kendler et al., 1993) and an
85% increase in men (Fanous et al., 2007). The strongest prospective study of neuroticism and
depression to date involved 20,692 adult members of same-sextwin pairs from the population-
based Swedish Twin Registry. Participants completed a measure of neuroticism in 1972–73
and were interviewed25 years later to determine if they had experienced major depression.
Excluding individuals with an episode of major depression before 1974, each 1 SD difference
in higher neuroticism was associated with a 31% greater risk for a first episode of major
depression over the 25-year period, controlling age, sex, and extroversion (Kendler, Gatz,
Gardner, & Pederse, 2006). Fewer studies of the utility of neuroticism in predicting other
mental disorders have been conducted, but a prospective study of a birth cohort of 5,362
individuals found the odds of later meeting criteria for schizophrenia to be 93% greater for
individuals with high neuroticism scores at age 16 (Van Os & Jones, 2001). In addition, a
longitudinal study of a New Zealand birth cohort found that risk for a suicide attempt at ages
15–21 years was 225% greater for youth in the highest quartile of neuroticism at age 14 than
for youth in the lowest quartile, controlling for socioeconomic status, sensation seeking,
NIH-PA Author Manuscript
depression and other mental disorders, and stressful life events (Fergusson, Woodward, &
Horwood, 2000). Moreover, these risk factors were related to suicide attempts multiplicatively,
such that the risk for a suicide attempt among youth with both high neuroticism scores and
other risk factors was 60 times greater than for low risk youth (Fergusson et al., 2000). This
suggests that the predictive validity of neuroticism may be particularly strong when considered
in the context of negative life events and other predictors.
The indirect evidence comes from studies showing strong links between physical health and
mental disorders that are themselves strongly linked with neuroticism, particularly depression
and anxiety disorders. A wide range of physical health problems are more common among
individuals with mood and anxiety disorders, which are strongly correlated with neuroticism
(Currie & Wang, 2005; Robles, Glaser, & Kiecolt-Glaser, 2005; Sareen, Cox, Clara, &
Asmundson, 2005; Watkins et al., 2006). Depression and anxiety disorders are associated with
disrupted immune functioning (Maier & Watkins, 1998; Pace et al., 2006; Robles et al.,
2005), abnormalities in cardiac functioning (Barger & Sydeman, 2005), and increased
mortality among individuals with other risk factors for cardiac disease (Penninx et al., 2001;
Robles et al., 2005; Simonsick, Wallace, Blaser, & Gerkman, 1995). Again, however, the
literature on anxiety and depression only provides indirect evidence regarding the association
of neuroticism with physical health problems that is subject to multiple interpretations.
Fortunately, there also is growing direct evidence that neuroticism is associated with physical
health problems. A number of studies suggest that neuroticism itself is associated with a wide
range of physical health problems (T. W. Smith & MacKenzie, 2006), such as cardiovascular
disease (Suls & Bunde, 2005), atopic eczema (Buske-Kirschbaum, Geiben, & Hellhammer,
2001), asthma (Huovinen, Kaprio, & Koskenvuo, 2001), and irritable bowel syndrome (Spiller,
NIH-PA Author Manuscript
2007), even when depression and other risk factors such as social support are controlled
(Bouhuys et al., 2004; Russo et al., 1997). Indeed, one study found that depression did not
predict poor physical health when neuroticism was controlled (Russo et al., 1997). Thus, the
association between neuroticism and physical health problems may not solely reflect the result
of the correlation of neuroticism with depression.
Furthermore, because neuroticism is associated with both mental and physical health problems,
it is likely that neuroticism is associated with comorbidity between mental and physical health
problems. This would greatly multiply the public health significance of neuroticism, as this
form of comorbidity is associated with more complicated health problems, greater need for
health services, and significantly poorer health outcomes (Baune, Adrian, & Jacobi, 2007;
Druss et al., in press; McCaffery et al., 2006).
from large studies of representative samples that neuroticism significantly predicts longevity
in the general population (T. W. Smith & MacKenzie, 2006). For example, a 21-year
prospective study of a representative sample of 5,424 British adults found that each 1 standard
deviation unit difference in greater neuroticism at baseline was associated with a statistically
significant 10% greater mortality from cardiovascular disease, controlling for age, sex,
socioeconomic status, smoking, alcohol consumption, physical activity, and initial health
(Shipley, Weiss, Der, Taylor, & Deary, 2007). Similarly, a 6-year longitudinal study of a
representative sample of 6,158 adults 65 years of age and older found that a high level of
neuroticism in the first assessment predicted 33% more deaths from all causes compared to
low neuroticism, controlling age, sex, race-ethnicity, education, medical conditions, and initial
health (Wilson et al., 2005). In addition, a 5-year longitudinal study of 800 elderly female and
male clergy found that participants with high neuroticism scores had nearly double the death
rate as those with low neuroticism scores (Wilson, Leon, Bienias, Evans, & Bennett, 2004). In
contrast, higher neuroticism did not predict mortality in a longitudinal study of 65- to 100-
year-old participants in frail health (Weiss & Costa, 2005).
There also is important evidence that neuroticism robustly predicts morbidity and mortality in
individuals with chronic diseases and cancer. For example, neuroticism strongly predicts the
NIH-PA Author Manuscript
course of renal deterioration in type I diabetics (Brickman et al., 1996) and patients with cardiac
disease (Murberg, 2004). In addition, a four-year prospective study of patients with chronic
renal insufficiency found that patients with high neuroticism scores had a 38% greater mortality
rate, controlling age, diabetic status, hemoglobin level, and the personality trait of
conscientiousness (Christensen et al., 2002). Similarly, a 25-year Danish longitudinal study
found that persons treated for cancer who were high in neuroticism had a 130% greater death
rate than persons low in neuroticism (Nakaya et al., 2006). Thus, it appears that neuroticism
is a robust predictor of future physical health problems and mortality.
& Goldberg, 2007), and overall quality of life (Arrindell, Heesink, & Feij, 1999; Lynn & Steel,
2006; Ozer & Benet-Martinez, 2006). Interestingly, there is recent evidence based on a large
and representative twin sample indicating that much of the genetic influences on subjective
well being are shared with neuroticism (Weiss, Bates, & Luciano, 2008).
Thus, overall, there is strong evidence from prospective studies that greater neuroticism is
related to adverse outcomes. Indeed, it predicts shorter, less happy, less healthy, and less
successful lives to a meaningful extent.
it is first necessary to review current evidence on the genetic and environmental causal
influences on neuroticism itself. This is because some of the causal influences on neuroticism
may also influence many of the mental and physical health outcomes and partly explain their
NIH-PA Author Manuscript
related to emotion. For example, the serotonergic system is known to be involved in emotion
processing (Leonardo & Hen, 2006). The association between a polymorphism (5-HTTLPR)
of the serotonin transporter gene and neuroticism has been investigated many times. This is
because the serotonin transporter is involved in the reuptake of serotonin from the synapse and
variations in transporter functioning can influence serotonergic transmission. The 5-HTTLPR
polymorphism is of particular interest because (a) it is a functional polymorphism that
influences gene products that influence activity of the serotonin transporter on neurons
(Haddley et al., 2008), and (b) because the serotonin transporter is the target of some
medications that are effective in treating anxiety and depression (Leonardo & Hen, 2006).
Three separate meta-analyses of published studies concluded that there is a small but significant
difference in neuroticism scores between persons with at least one short 5-HTTLPR allele and
persons with only long alleles (Schinka, 2005; Schinka, Busch, & Robichaux-Keene, 2004;
Sen, Burmeister, & Ghosh, 2004, 2005). A fourth meta-analysis initially did not find a
significant association between 5-HTTLPR and neuroticism (Munafo et al., 2003), but a
revised and updated report of this meta-analysis confirmed the significant association between
5-HTTLPR and neuroticism (Munafo, Clark, & Flint, 2005). This conclusion is consistent with
findings that variations in the serotonin transporter gene in mice are related to behaviors
NIH-PA Author Manuscript
suggestive of emotionality that may be analogous to neuroticism (Leonardo & Hen, 2006;
Murphy & Lesch, 2008). In addition, functional magnetic resonance imaging has revealed that
variations in alleles of 5-HTTLPR are related to variations in the activation of the amygdala
and related brain structures in response to threatening stimuli (Brown & Hariri, 2006; Hariri
et al., 2002; Passamonti et al., 2008). Because anatomic and functional variations in the same
brain structures have been linked to variations in neuroticism (Canli, 2004; Haas, Omura,
Constable, & Canli, 2007; Omura, Constable, & Canli, 2005), this research also supports the
hypothesis that polymorphisms of 5-HTTLPR are linked to neuroticism.
In addition to the serotonin transporter, there is evidence from candidate gene studies that
polymorphisms that encode serotonin receptors also are related to neuroticism. This comes
from studies of both humans (including genomic imaging studies) and genetically modified
mice and includes the 5-HT1A and 5-HTR2A receptors (Golimbet et al., 2002; Lesch & Canli,
2006). Similarly, the G72 gene, which influences glutamate receptor function, has been found
Several genetic studies of neuroticism not involving the advance specification of candidate
genes also have been conducted. Genome-wide linkage studies, which use large numbers of
markers selected from across the genome to examine patterns of inheritance within families,
have not yielded consistent findings (Fullerton et al., 2003; Nash et al., 2004), perhaps partly
because of limitations in the statistical power of linkage studies (Risch & Merikangas, 1996).
A more powerful recent genome-wide association study of unrelated individuals failed to find
significant associations between single nucleotide polymorphisms (SNPs) and neuroticism
(Shifman et al., 2008), but another recent study found associations of neuroticism and SNPs
in MAMDC1 (van den Oord et al., 2008).
shared aspects of the environmental influences exert causal influences on neuroticism, but do
so through gene-environment interactions.
At this point in time, very little is known about the specific shared and nonshared environmental
experiences that influence neuroticism. Several studies have found modest correlations
between neuroticism scores in adults and their retrospective recall of intrusive parenting (Reti
et al., 2002), having been abused during childhood (Allen & Lauterbach, 2007; Roy, 2002),
lack of religious upbringing (Willemsen & Boomsma, 2007), and low parental involvement
(McCrae & Costa, 1988) when they were children. A search of the literature did not locate any
published studies that prospectively linked parenting in childhood to the offspring’s later
neuroticism, however. Retrospective studies are useful for generating hypotheses about
potential environmental influences on personality, but they are highly subject to potentially
serious recall biases. Thus, there is a clear and pressing need for longitudinal studies that can
test hypotheses prospectively regarding the causal influence of specific experiences on later
neuroticism (Rutter, 2007b). These would need to determine that such early experiences
influence future neuroticism when early measures of neuroticism are controlled and rule out
NIH-PA Author Manuscript
relevant confounds, such as shared genetic influences between the experience and neuroticism.
It is essential that future studies of causal environmental influences on neuroticism not be
conducted in isolation, however, but take the interplay of genes and environments fully into
consideration (Johnson, 2007; Robinson, 2004).
mental disorders are correlated partly because they are partly influenced by the same genes
(Hettema, Neale, Myers, Prescott, & Kendler, 2006; Silberg, Rutter, Neale, & Eaves, 2001;
Stein & Stein, 2008). Indeed, twin studies indicate that one-third to two-thirds of the genetic
variance in broad range of mental disorders is shared with neuroticism (Carey & DiLalla,
1994; Fanous, Gardner, Prescott, Cancro, & Kendler, 2002; Hettema, Neale et al., 2006). It is
not surprising, then, that the genetic influences on neuroticism also increase risk for
comorbidity among the many forms of mental disorders correlated with neuroticism (Khan et
al., 2005).
There is mounting evidence that the 5-HTTLPR polymorphism may be one of the specific
genetic variants that influence both neuroticism and the mental disorders correlated with it.
For example, persons with at least one copy of the short allele of 5-HTTLPR drink more alcohol
than persons with two long alleles (Munafo, Lingford-Hughes, Johnstone, & Walton, 2005).
This is potentially important because neuroticism is associated with this polymorphism and
higher neuroticism scores are associated with alcohol use disorders (Khan et al., 2005; Malouff
et al., 2005). There also is consistent evidence that the short allele of 5-HTTLPR is associated
with increased risk for depression among persons who have experienced stressful life events
(Caspi et al., 2003; Lotrich & Pollock, 2004; Uher & McGuffin, 2008). Indeed, 17 studies have
NIH-PA Author Manuscript
Furthermore, the interaction of 5-HTTLPR and stressful life events has been substantiated in
genomic imaging studies. For example, activation of the amygdala and hippocampus in
response to faces varies dramatically according to the number of stressful life events
experienced by the individual, but particularly in persons with at least one short allele of 5-
HTTLPR (Canli et al., 2006). Furthermore, two studies found that neuroticism entirely
mediates the association between the 5-HTTLPR gene and depression (Jacobs et al., 2006;
Munafo, Clark, Roberts, & Johnstone, 2006). In addition, the results of a number of cognate
studies of non-human animals are consistent with the hypothesis that variants of the serotonin
transporter gene interact with stress levels to influence negative emotionality (Caspi & Moffitt,
2006). There also is growing evidence that the G72 gene, which is associated with neuroticism,
is also associated with major depression and schizophrenia (Rietschel et al., in press; Shi,
Badner, Gershon, & Liu, 2008), suggesting that G72 could prove to be another gene that
increases risk for both high neuroticism and some of the mental disorders that are correlated
with it.
NIH-PA Author Manuscript
To consider just one specific example of neuroticism influencing risk for negative life events,
NIH-PA Author Manuscript
a number of longitudinal studies have shown that the neuroticism scores of both partners
measured before marriage predict future separation or divorce (Donnellan, Conger, & Bryant,
2004; Karney & Bradbury, 1997; Kelly & Conley, 1987; Roberts et al., 2007; Rogge, Bradbury,
Hahlweg, Engl, & Thurmaier, 2006; Tucker, Kressin, Spiro, & Ruscio, 1998). Because other
longitudinal studies have shown that divorce predicts mental health problems, substance abuse,
and mortality (Hemström, 1996; Ikeda et al., 2007;C. Lee & Gramotnev, 2007; S. Lee et al.,
2005; Overbeek et al., 2006; Perreira & Sloan, 2001), it is reasonable to hypothesize that
neuroticism indirectly promotes adverse outcomes partly by increasing the likelihood of
divorce.
Similarly, there is evidence that neuroticism predicts lower levels of social support (Kendler,
Gardner, & Prescott, 2002; Kendler, Gardner, & Prescott, 2006). This could mean that
individual differences in neuroticism are one factor influencing the initiation and maintenance
of supportive social relationships. This could be important because social support is linked
with depression and partially mediates the association between neuroticism and depression
(Finch & Graziano, 2001; Kendler et al., 2002; Kendler, Gardner et al., 2006). Furthermore,
greater social support predicts shorter episodes of depression in prospective studies (Lara,
Leader, & Klein, 1997; Neeleman, Oldehinkel, & Ormel, 2003).
NIH-PA Author Manuscript
Coping style may be an important component of the greater emotional reactivity of persons
high in neuroticism (Matthews et al., 2003). There is evidence that persons high in neuroticism
use fewer problem-focused and more emotion-focused strategies to cope with stress (Watson
NIH-PA Author Manuscript
& Hubbard, 1996). In addition, there is evidence that persons high in neuroticism are more
likely to use inefficient escape-avoidance strategies to cope with stress (Bolger, 1990). Thus,
it appears that persons high in neuroticism have both an increased likelihood of experiencing
negative life events and an increased magnitude of emotional reactivity to those events, partly
because of how they cope with stress.
In addition, two other specific causal mechanisms have been hypothesized through which
neuroticism may be linked to physical health problems that may not be involved in mental
health problems. First, it is possible that higher neuroticism is associated with greater
sympathetic and hypothalamic-pituitary-adrenal (HPA) reactivity and with greater alterations
of the immune system in response to stressful life events (Futterman, Kemeny, Shapiro, &
Fahey, 1994; Gillespie et al., 2004). In turn, these enhanced physiological responses to stress
may contribute to health problems (Contrada et al., 1999; Friedman, 2000;T. W. Smith &
MacKenzie, 2006). Second, it is likely that persons high in neuroticism are more likely to
engage in behaviors that increase the risk of health problems (Contrada et al., 1999).
Carroll, Burns, & Drayson, 2005). Hormonal challenge studies suggest that this blunted cortisol
stress response in individuals with high neuroticism scores may reflect down-regulation of the
HPA system due to prolonged cortisol elevation (McCleery & Goodwin, 2001; Zobel et al.,
2004). Neuroticism also is related to disruption of circadian rhythms (Murray, Allen, Trinder,
& Burgess, 2002) and is correlated with abnormalities of the immune system (Bouhuys et al.,
2004). Higher neuroticism has been found to be associated with more prolonged suppression
of secretory immunoglobulin following a stressor (Hennig, Possel, & Netter, 1996), atypical
response of natural killer cells to stress (Borella et al., 1999), diminished antibody response to
vaccination (Phillips et al., 2005), and higher leukocyte counts (Daruna, 1996). Leukocyte
count is important because it is indicator of inflammation and chronic infection and is a strong
predictor of mortality from all causes, particularly from cardiovascular disease (Margolis et
al., 2005).
In contrast, some studies have not found neuroticism to be related to differences in cortisol
reactivity to a stressor (Hennig et al., 1996; Schommer, Kudielka, Hellhammer, & Kirschbaum,
1999) and one study found that higher neuroticism was associated with lower heart rate and
NIH-PA Author Manuscript
lower levels of serum norepinephrine during an aversive challenge (LeBlanc, Ducharme, &
Thompson, 2004). Such discrepancies may be the result of the generally small samples used
in this area of research, nonlinear associations between neuroticism and stress reactivity,
methodological differences across studies, and demographic differences in samples. For
example, there is some evidence that the greater physiological responsiveness associated with
higher neuroticism is considerably more robust in females than in males (Hennig et al., 1996;
Oswald et al., 2006). It will be very important to consider such factors when attempting to
resolve these discrepancies and test the important hypothesis that neuroticism moderates
health-related physiological responsiveness to stressors.
There is emerging evidence from twin studies that the hypothesized moderation of
physiological reactivity by neuroticism may be partly due to some genes influencing both
neuroticism and physiological reactivity (Riese et al., 2007). At the molecular level, persons
with at least one copy of the short allele of 5-HTTLPR have been found to have higher resting
cortisol levels than persons with two long alleles (Jabbi et al., 2007). Similarly, the association
between neuroticism and some health problems may reflect common genetic influences. For
example, irritable bowel syndrome is associated with neuroticism (Spiller, 2007) and the short
allele of 5-HTTLPR has been found to be associated with irritable bowel syndrome in humans
NIH-PA Author Manuscript
(Yeo et al., 2004) and with analogous bowel dysfunctions in mice (Murphy & Lesch, 2008).
OUTCOMES?
Ultimately, the public health significance of neuroticism hinges on whether knowledge that
neuroticism is a potent risk factor for many adverse outcomes can be translated into the
prevention of those outcomes. Perhaps the most likely way in which this is could happen is
through improved understanding of the basic nature of each of the health and mental health
problems associated with neuroticism. That is, achieving a full understanding of why each
disorder is related to neuroticism is almost certain to advance our understanding of both
neuroticism and each disorder. Indeed, understanding why high neuroticism places persons at
increased risk for such seemingly diverse outcomes as depression, schizophrenia, diabetes,
asthma, irritable bowel syndrome, and heart disease could change how we conceptualize each
of these disorders in fundamentally important ways. Because improved understanding often
leads to improved prevention and treatment, discovering how neuroticism is related to each
outcome should eventually lead to improved, and potentially innovative, ways of preventing
and alleviating each of the many health and mental health problems linked to neuroticism.
NIH-PA Author Manuscript
First, persons with high scores on the screen could be advised to obtain further individual
physical and mental health “check ups” that would include tests specific to each of the mental
or physical disorders associated with neuroticism (e.g., tests for cognitive and emotional
vulnerability to suicide or tests for high cholesterol). Individuals found to be at risk for any
specific adverse outcome using those tests, could then be provided with interventions tailored
to their needs (e.g., cognitive-behavior therapy and antidepressants to reduce risk of suicide or
statins to reduce cholesterol). If much higher proportions of screen positives than screen
negatives were found to be at high risk for one or more of the specific adverse outcomes, such
NIH-PA Author Manuscript
a strategy might prove to be an effective method of identifying at-risk persons. That would
only be the case, however, if substantial numbers of persons were found to be at risk for a
condition that had not been identified in other ways, such as during routine medical visits. For
example, it is possible that few persons would be discovered by screening on neuroticism who
did not already know that they were at risk for cardiovascular disease. Even so, a potential
benefit of wide-spread screening on neuroticism might be the inexpensive early detection of
at-risk persons at an early stage when preventive interventions would be most helpful.
The potential benefits of such large scale screening on neuroticism also would need to be
balanced against the numbers of false positives, however. That is, if even if the threshold for
the screen was carefully set, any foreseeable screen will identify some persons who screen high
on neuroticism but are not actually at high risk for any adverse outcome. This is an issue of
concern because persons who are incorrectly identified as being at high risk for serious physical
or medical disorders using measures of neuroticism could experience unnecessary worry and
subject an already over-burdened health care system to unnecessary expense. In addition, the
use of neuroticism scales as a screening measure could tend to stigmatize diversity in this
dimension of normal personality.
NIH-PA Author Manuscript
There has been a trend in the United States toward lowering thresholds for physical health
indices such as blood pressure and cholesterol for the purpose of identifying more people in
need of preventive treatment. Recent analyses suggest that this may have yielded little increase
in health benefits, but may have caused increases in adverse side effects because more
individuals are being treated, adverse consequences of labeling, and the diversion of funds
from potentially more effective health programs (Kaplan & Ong, 2007). Much remains to be
learned about this topic, but the same clearly could happen with neuroticism if the specificity
of the screen was low and/or the screening threshold was set too low. Great caution should be
exercised as we consider the potential utility and wisdom of screening on neuroticism to
identify people in need of interventions. Nonetheless, because neuroticism is robustly related
to so many different adverse outcomes, this approach to prevention should not be prematurely
passed over just because it is challenging.
A second possible innovative approach based on screening for neuroticism might be to attempt
to reduce high levels of neuroticism in order to indirectly reduce risks for all of the many mental
and physical health problems associated with it. Even if the indirect reduction in the prevalence
NIH-PA Author Manuscript
of each individual adverse outcome were modest, it is possible that such a strategy could be
cost-effective because of the sheer number of adverse outcomes associated with neuroticism.
To date, no interventions for reducing neuroticism have been identified, but such interventions
seem feasible.
The potential utility of this approach to prevention would depend both on the safety, cost, and
effectiveness of reducing neuroticism and on the extent to which reducing neuroticism actually
resulted in reductions in the adverse health and mental health outcomes associated with
neuroticism, all of which are currently unknown. The utility of such large-scale preventive
interventions would depend partly on whether reducing neuroticism requires interventions
more like supplementing drinking water with fluoride to prevent dental carries than like long-
term individual psychotherapy. Assuming for the sake of argument that they were effective in
reducing neuroticism, encouraging people with high neuroticism scores to use inexpensive
interventions with few adverse side effects such as participation in moderate physical exercise
(Koukouvou et al., 2004) or taking omega-3 dietary supplements (Conklin et al., 2007) might
be cost-effective, even if they yielded only modest reductions in each of the many adverse
outcomes associated with neuroticism. More expensive interventions would need to produce
larger decreases in physical and mental disorders to be cost-effective. Although much remains
NIH-PA Author Manuscript
Any serious discussion of preventive intervention targeting neuroticism also must consider
other possible negative iatrogenic effects. Because wide-spread preventive interventions to
reduce neuroticism might even have the unintended effect of reducing adaptive levels of
fearfulness and wariness to unsafe levels in some persons, care would need to be taken. This
concern might be minimized by intervening only with persons with high levels of neuroticism
NIH-PA Author Manuscript
who requested the intervention, but in some dangerous environments in which cues signaling
danger are subtle, such as some urban environments, even relatively high levels of neuroticism
might be adaptive in some cases (Matthews et al., 2003).
enormous significance to the public health, an intensive research effort to fully understand
relations among neuroticism, mental health, physical health, and quality of life would be well
justified. A number of detailed causal models of the multiple mechanisms linking neuroticism
and physical health outcomes have been proposed (Contrada et al., 1999;T. W. Smith, 2006).
These need further testing and similar causal models for mental health outcomes need testing.
It is likely that the best-supported and most useful constructs from each alternative model could
be combined to create more comprehensive and useful models. Furthermore, it could be very
useful and revealing to develop truly integrated models that would simultaneously explain
causal relations between neuroticism and both mental and physical health outcomes in the same
model. These adverse outcomes share too much in common to be treated entirely separately
in such models. Moreover, including both physical and mental health outcomes in the same
models will reveal much about their previously underestimated commonalities.
In addition, the time is right to invest in a better understanding of the genetic and environmental
factors that influence neuroticism and play a role in linking it to adverse outcomes. Current
evidence strongly suggests that many of the genes influencing neuroticism function as
pleiotropic general risk genes that also influence risk for many different mental disorders
(Hettema, Neale et al., 2006; Jang & Livesley, 1999) and many different physical health
NIH-PA Author Manuscript
problems (Johnson & Krueger, 2005; McCaffery et al., 2006). Therefore, identifying the genes
associated with neuroticism and their interplay with environmental factors should be a top
priority for both mental and physical health research. A plausible working model for future
studies is that that the etiology of each mental and physical health disorder results from the
combined interplay of general-risk genes and environments and disorder-specific genes and
environments (Gillespie et al., 2004; Khan et al., 2005; Lahey & Waldman, 2003). To fully
understand the etiology of each disorder, it will be necessary to identify each of these factors
and how they work together. Understanding the causal pathways linking neuroticism to the
many adverse outcomes associated with it will likely reveal a great deal about commonalities
in the mechanisms underlying many seemingly distinct mental health and health problems.
This should facilitate the development of both integrated causal models and innovative
interventions for preventing and treating the many adverse outcomes associated with
neuroticism.
Acknowledgments
The content of this paper greatly benefited from the exceptionally helpful comments and suggestions of the action
editor and reviewers. It also owes important intellectual debts to Irwin D. Waldman and Brian M. D’Onofrio for
NIH-PA Author Manuscript
patiently and expertly tutoring the author in genetics and gene-environment interplay.
References
Akiskal HS, Kilzieh N, Maser JD, Clayton PJ, Schettler PJ, Shea MT, et al. The distinct temperament
profiles of bipolar I, bipolar II and unipolar patients. Journal of Affective Disorders 2006;92:19–33.
[PubMed: 16635528]
Allen B, Lauterbach D. Personality characteristics of adult survivors of childhood trauma. Journal of
Traumatic Stress 2007;20:587–595. [PubMed: 17721954]
Antoni MH, Cruess DG, Cruess S, Lutgendorf S, Kumar M, Ironson G, et al. Cognitive-behavioral stress
management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/
suppressor cells over time among symptomatic HIV-infected gay men. Journal of Consulting and
Clinical Psychology 2000;68:31–45. [PubMed: 10710838]
Arrindell WA, Heesink J, Feij JA. The Satisfaction With Life Scale (SWLS): Appraisal with 1700 health
young adults in The Netherlands. Personality and Individual Differences 1999;26:815–826.
Barger SD, Sydeman SJ. Does generalized anxiety disorder predict coronary heart disease risk factors
independently of major depressive disorder? Journal of Affective Disorders 2005;88:87–91. [PubMed:
16009431]
NIH-PA Author Manuscript
Baune BT, Adrian I, Jacobi F. Medical disorders affect health outcome and general functioning depending
on comorbid major depression in the general population. Journal of Psychosomatic Research
2007;62:109–118. [PubMed: 17270568]
Bienvenu OJ, Ginsburg GS. Prevention of anxiety disorders. International Review of Psychiatry
2007;19:647–654. [PubMed: 18092242]
Bolger N. Coping as personality process: A prospective study. Journal of Personality and Social
Psychology 1990;59:525–537. [PubMed: 2231283]
Bolger N, Zuckerman A. A framework for studying personality in the stress process. Journal of
Personality and Social Psychology 1995;69:890–902. [PubMed: 7473036]
Borella P, Bargellini A, Rovesti S, Pinelli M, Vivoli R, Solfrini V, et al. Emotional stability, anxiety, and
natural killer activity under examination stress. Psychoneuroendocrinology 1999;24:613–627.
[PubMed: 10399771]
Bouhuys AL, Flentge F, Oldehinkel AJ, van den Berg MD. Potential psychosocial mechanisms linking
depression to immune function in elderly subjects. Psychiatry Research 2004;127:237–245.
[PubMed: 15296823]
Breslau N, Novak SP, Kessler RC. Psychiatric disorders and stages of smoking. Biological Psychiatry
2004;55:69–76. [PubMed: 14706427]
Brickman AL, Yount SE, Blaney NT, Rothberg ST, De-Nour AK. Personality traits and long-term health
NIH-PA Author Manuscript
status. The influence of neuroticism and conscientiousness on renal deterioration in type-1 diabetes.
Psychosomatics 1996;37:459–468. [PubMed: 8824126]
Brown SM, Hariri AR. Neuroimaging studies of serotonin gene polymorphisms: Exploring the interplay
of genes, brain, and behavior. Cognitive, Affective & Behavioral Neuroscience 2006;6:44–52.
Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological Aspects of Atopic Dermatitis: An
Overview. Psychotherapy and Psychosomatics 2001;70:6–16. [PubMed: 11150933]
Canli T. Functional brain mapping of extraversion and neuroticism: Learning from individual differences
in emotion processing. Journal of Personality 2004;72:1105–1132. [PubMed: 15509278]
Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z, et al. Neural correlates of epigenesis.
Proceedings of the National Academy of Sciences of the United States of America 2006;103:16033–
16038. [PubMed: 17032778]
Carey G, DiLalla DL. Personality and psychopathology: Genetic perspectives. Journal of Abnormal
Psychology 1994;103:32–43. [PubMed: 8040478]
Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: Joining forces with neuroscience.
Nature Reviews Neuroscience 2006;7:583–590.
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on
depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386–389.
[PubMed: 12869766]
NIH-PA Author Manuscript
Chaturvedi SK. Chronic idiopathic pain disorder. Journal of Psychosomatic Research 1986;30:199–203.
[PubMed: 3723450]
Chien LL, Koa HC, Wub JYW. The five-factor model of personality and depressive symptoms: One-
year follow-up. Personality and Individual Differences 2007;43:1013–1023.
Christensen AJ, Ehlers SL, Wiebe JS, Moran PJ, Raichle K, Ferneyhough K, et al. Patient personality
and mortality: a 4-year prospective examination of chronic renal insufficiency. Health Psychology
2002;21:315–320. [PubMed: 12090673]
Clark LA, Watson D, Mineka S. Temperament, personality, and the mood and anxiety disorders. Journal
of Abnormal Psychology 1994;103:103–116. [PubMed: 8040472]
Cohen, J. Statistical power analysis for the behavioral sciences (2nd ed). Hillsdale, NJ: Lawrence
Erlbaum; 1988.
Conklin SM, Manuck SB, Yao JK, Flory JD, Hibbeln JR, Muldoon MF. High omega-6 and low omega-3
fatty acids are associated with depressive symptoms and neuroticism. Psychosomatic Medicine
2007;69:932–934. [PubMed: 17991818]
Contrada, RJ.; Cather, C.; O’Leary, A. Personality and health: Dispositions and processes in disease
susceptibility and adaptation to illness. In: Pervin, LA.; John, OP., editors. Handbood of personality.
Vol. 2. New York: Guilford; 1999. p. 576-604.
NIH-PA Author Manuscript
Cooper ML, Agocha VB, Sheldon MS. A motivational perspective on risky behaviors: The role of
personality and affect regulatory processes. Journal of Personality 2000;68:1059–1088. [PubMed:
11130732]
Costa PT, McCrae RR. Neuroticism, somatic complaints and disease: Is the bark worse than the bite.
Journal of Personality 1987;55:299–316. [PubMed: 3612472]
Costa PT, McCrae RR. Four ways five factors are basic. Personality and Individual Differences 1992a;
13:653–665.
Costa, PT.; McCrae, RR. NEO five-factor inventory. Lutz, FL: Psychological Assessment Resources;
1992b.
Costa PT, Terracciano A, McCrae RR. Gender differences in personality traits across cultures: Robust
and surprising findings. Journal of Personality and Social Psychology 2001;81:322–331. [PubMed:
11519935]
Costa, PT.; Widiger, TA., editors. Personality disorders and the five-factor model of personality. 2.
Washington, DC: American Psychological Association; 2002.
Cruess DG, Antoni MH, Klimas N, Maher K, Cruess SE, Kumar M, et al. Stress management and immune
system reconstitution in symptomatic HIV-positive men: Effects on transitional naive T-cells.
Psychosomatic Medicine 2000;62:102–103.
Currie SR, Wang J. More data on major depression as an antecedent risk factor for first onset of chronic
NIH-PA Author Manuscript
Fullerton J. New approaches to the genetic analysis of neuroticism and anxiety. Behavior Genetics
2006;36:147–161. [PubMed: 16365832]
Fullerton J, Cubin M, Tiwari H, Wang C, Bomhra A, Davidson S, et al. Linkage analysis of extremely
NIH-PA Author Manuscript
discordant and concordant sibling pairs identifies quantitative trait loci that influence variation in the
human personality trait neuroticism. American Journal of Human Genetics 2003;72:879–890.
[PubMed: 12612864]
Futterman AD, Kemeny ME, Shapiro D, Fahey JL. Immunological and physiological changes associated
with induced positive and negative mood. Psychosomatic Medicine 1994;56:499–511. [PubMed:
7871105]
Gattis KS, Berns S, Simpson LE, Christensen A. Birds of a feather or strange birds? Ties among
personality dimensions, similarity, and marital quality. Journal of Family Psychology 2004;18:564–
574. [PubMed: 15598162]
Gillespie NA, Evans DE, Wright MM, Martin NG. Genetic simplex modeling of Eysenck’s dimensions
of personality in a sample of young Australian twins. Twin Research 2004;7:637–648. [PubMed:
15607015]
Goldberg LR. The structure of phenotypic personality traits. American Psychologist 1993;48:26–34.
[PubMed: 8427480]
Golimbet VE, Alfimova MV, Manandyan KK, Mitushina NG, Abramova LI, Kaleda VG, et al. 5HTR2A
gene polymorphism and personality traits in patients with major psychoses. European Psychiatry
2002;17:24–28. [PubMed: 11918989]
Goubert L, Crombez G, Van Damme S. The role of neuroticism, pain catastrophizing and pain-related
NIH-PA Author Manuscript
Heino A, van der Molen HH, Wilde GJS. Risk perception, risk taking, accident involvement and the need
for stimulation. Safety Science 1996;22:35–48.
Hemström O. Does marital dissolution lead to differences in mortality risk for men and women? Journal
of Marriage and Family 1996;58:366–378.
Hennig J, Possel P, Netter P. Sensitivity to disgust as an indicator of neuroticism: A psychobiological
approach. Personality and Individual Differences 1996;20:589–596.
Hettema JM, An SS, Neale MC, Bukszar J, van den Oord EJCG, Kendler KS, et al. Association between
glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism.
Molecular Psychiatry 2006;11:752–762. [PubMed: 16718280]
Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. A population-based twin study of the
relationship between neuroticism and internalizing disorders. American Journal of Psychiatry
2006;163:857–864. [PubMed: 16648327]
Holt-Lunstad J, Smith TW, Uchino BN. Can hostility interfere with the health benefits of giving and
receiving social support? The impact of cynical hostility on cardiovascular reactivity during social
Johnson W. Genetic and environmental influences on behavior: Capturing all of the interplay.
Psychological Review 2007;114:423–440. [PubMed: 17500633]
Johnson W, Krueger RF. Predictors of physical health: Toward an integrated model of genetic and
environmental antecedents. Journals of Gerontology: Series B: Psychological Sciences and Social
Sciences 2005;60B:42–52.
Judge TA, Higgins CA, Thoresen CJ, Barrick MR. The big five personaltiy traits, general mental ability,
and career success across the life span. Personnel Psychology 1999;52:621–652.
Jylha P, Isometsa E. The relationship of neuroticism and extraversion to symptoms of anxiety and
depression in the general population. Depression and Anxiety 2006;23:281–289. [PubMed:
16688731]
Kaplan RM, Ong M. Rationale and public health implications of changing CHD risk factor definitions.
Annual Review of Public Health 2007;28:321–344.
Karney BR, Bradbury TN. Neuroticism, marital interaction, and the trajectory of marital satisfaction.
Journal of Personality and Social Psychology 1997;72:1075–1092. [PubMed: 9150586]
Kelly EL, Conley JJ. Personality and compatibility: A prospective analysis of marital stability and marital
satisfaction. Journal of Personality and Social Psychology 1987;52:27–40. [PubMed: 3820076]
Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major
depression in women. American Journal of Psychiatry 2002;159:1133–1145. [PubMed: 12091191]
NIH-PA Author Manuscript
Kendler KS, Gardner CO, Prescott CA. Personality and the experience of environmental adversity.
Psychological Medicine 2003;33:1193–1202. [PubMed: 14580074]
Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major
depression in men. American Journal of Psychiatry 2006;163:115–124. [PubMed: 16390898]
Kendler KS, Gatz M, Gardner CO, Pederse NL. Personality and major depression. Archives of General
Psychiatry 2006;63:1113–1120. [PubMed: 17015813]
Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex, and stressful life events in
the prediction of episodes of major depression. American Journal of Psychiatry 2004;161:631–636.
[PubMed: 15056508]
Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. A longitudinal twin study of personality and
major depression in women. Archives of General Psychiatry 1993;50:853–862. [PubMed: 8215811]
Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-
IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry
2005;62:617–627. [PubMed: 15939839]
Khan AA, Jacobson KC, Gardner CO, Prescott CA, Kendler KS. Personality and comorbidity of common
psychiatric disorders. British Journal of Psychiatry 2005;186:190–196. [PubMed: 15738498]
Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, et al. Selective alteration of
NIH-PA Author Manuscript
[PubMed: 15918078]
Lara ME, Leader J, Klein DN. The association between social support and course of depression: Is it
confounded with personality? Journal of Abnormal Psychology 1997;106:478–482. [PubMed:
9241950]
Larkins JM, Sher KJ. Family history of alcoholism and the stability of personality in young adulthood.
Psychology of Addictive Behaviors 2006;20:471–477. [PubMed: 17176182]
Larsen RJ, Ketelaar T. Personality and susceptibility to positive and negative emotional states. Journal
of Personality and Social Psychology 1991;61:132–140. [PubMed: 1890584]
LeBlanc J, Ducharme MB, Thompson M. Study on the correlation of the autonomic nervous system
responses to a stressor of high discomfort with personality traits. Physiology and Behavior
2004;82:647–652. [PubMed: 15327912]
Lee C, Gramotnev H. Life transitions and mental health in a national cohort of young Australian women.
Developmental Psychology 2007;43:877–888. [PubMed: 17605521]
Lee S, Cho E, Grodstein F, Kawachi I, Hu FB, Colditz GA. Effects of marital transitions on changes in
dietary and other health behaviours in US women. International Journal of Epidemiology
2005;34:69–78. [PubMed: 15231759]
Leonardo ED, Hen R. Genetics of affective and anxiety disorders. Annual Review of Psychology
2006;57:117–137.
NIH-PA Author Manuscript
Lesch, KP.; Canli, T. 5-HT1A receptor and anxiety-related traits: Pharmacology, genetics, and imaging.
In: Canli, T., editor. Biology of personality and individual differences. New York: Guilford; 2006.
p. 273-294.
Lotrich FE, Pollock BG. Meta-analysis of serotonin transporter polymorphisms and affective disorders.
Psychiatric Genetics 2004;14:121–129. [PubMed: 15318024]
Lynn M, Steel P. National differences in subjective well-being: The interactive effects of extraversion
and neuroticism. Journal of Happiness Studies 2006;7:155–165.
Macaskill GT, Hopper JL, White V, Hill DJ. Genetic and environmental variation in Eysenck Personality
Questionnaire scales measured on Australian adolescent twins. Behavior Genetics 1994;24:481–
491. [PubMed: 7872928]
Magnus K, Diener E, Fujita F, Pavot W. Extraversion and neuroticism as predictors of objective life
events: A longitudinal analysis. Journal of Personality and Social Psychology 1993;65:1046–1053.
[PubMed: 8246112]
Maier SF, Watkins LR. Cytokines for psychologists: Implications of bi-directional immune-to-brain
communication for understanding behavior, mood, and cognition. Psychological Review
1998;105:83–107. [PubMed: 9450372]
NIH-PA Author Manuscript
Malouff JM, Thorsteinsson EB, Rooke SE, Schutte NS. Alcohol involvement and the five-factor model
of personality: A meta-analysis. Journal of Drug Education 2007;37:277–294. [PubMed: 18047183]
Malouff JM, Thorsteinsson EB, Schutte NS. The relationship between the five-factor model of personality
and symptoms of clinical disorders: A meta-analysis. Journal of Psychopathology and Behavioral
Assessment 2005;27:101–114.
Malouff JM, Thorsteinsson EB, Schutte NS. The five-factor model of personality and smoking: A meta-
analysis. Journal of Drug Education 2006;36:47–58. [PubMed: 16981639]
Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, et al. Leukocyte count as a
predictor of cardiovascular events and mortality in postmenopausal women: The Women’s Health
Initiative Observational Study. Archives of Internal Medicine 2005;165:500–508. [PubMed:
15767524]
Matthews, G.; Deary, IJ.; Whiteman, MC. Personality traits. Cambridge, UK: Cambridge University
Press; 2003.
McCaffery JM, Frasure-Smith N, Dube MP, Theroux P, Rouleau GA, Duan Q, et al. Common genetic
vulnerability to depressive symptoms and coronary artery disease: A review and development of
candidate genes related to inflammation and serotonin. Psychosomatic Medicine 2006;68:187–200.
[PubMed: 16554382]
McCleery JM, Goodwin GM. High and low neuroticism predict different cortisol responses to the
NIH-PA Author Manuscript
Munafo MR, Clark LA, Roberts KH, Johnstone EC. Neuroticism mediates the association of the serotonin
transporter gene with lifetime major depression. Neuropsychobiology 2006;53:1–8. [PubMed:
16319503]
Munafo MR, Clark T, Flint J. Promises and pitfalls in the meta-analysis of genetic association studies:
A response to Sen and Schinka. Molecular Psychiatry 2005;10:895–897.
Munafo MR, Clark TG, Moore LR, Payne E, Walton R, Flint J. Genetic polymorphisms and personality
in healthy adults: A systematic review and meta-analysis. Molecular Psychiatry 2003;8:471–484.
[PubMed: 12808427]
Munafo MR, Lingford-Hughes AR, Johnstone EC, Walton R. Association between the serotonin
transporter gene and alcohol consumption in social drinkers. American Journal of Medical Genetics
Part B: Neuropsychiatric Genetics 2005;135:10–14.
Murberg TA. Long-term effect of social relationships on mortality in patients with congestive heart
failure. International Journal of Psychiatry in Medicine 2004;34:207–217. [PubMed: 15666956]
Murphy DL, Lesch KP. Targeting the murine serotonin transporter: insights into human neurobiology.
Nature Reviews Neuroscience 2008;9:85–96.
[PubMed: 17596178]
Omura K, Constable RT, Canli T. Amygdala gray matter concentration is associated with extraversion
and neuroticism. Neuroreport: For Rapid Communication of Neuroscience Research
2005;16:1905–1908.
Ormel J, Wohlfarth T. How neuroticism, long-term difficulties, and life situation change influence
psychological distress: A longitudinal model. Journal of Personality and Social Psychology
1991;60:744–755. [PubMed: 2072254]
Oswald LM, Zandi P, Nestadt G, Potash JB, Kalaydjian AE, Wand GS. Relationship between cortisol
responses to stress and personality. Neuropsychopharmacology 2006;31:1583–1591. [PubMed:
16407895]
Overbeek G, Vollebergh W, RdG, Scholte R, de Kemp R, Engels R. Longitudinal associations of marital
quality and marital dissolution with the incidence of DSM-III-R disorders. Journal of Family
Psychology 2006;20:284–291. [PubMed: 16756404]
Ozer DJ, Benet-Martinez V. Personality and the prediction of consequential outcomes. Annual Review
of Psychology 2006;57:401–421.
Pace TWW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, et al. Increased stress-
induced inflammatory responses in male patients with major depression and increased early life
stress. American Journal of Psychiatry 2006;163:1630–1633. [PubMed: 16946190]
Parslow RA, Jorm AF, Christensen H. Associations of pre-trauma attributes and trauma exposure with
NIH-PA Author Manuscript
screening positive for PTSD: Analysis of a community-based study of 2085 young adults.
Psychological Medicine 2006;36:387–395. [PubMed: 16255836]
Passamonti L, Cerasa A, Gioia MC, Magariello A, Muglia M, Quattrone A, et al. Genetically dependent
modulation of serotonergic inactivation in the human prefrontal cortex. Neuroimage 2008;40:1264–
1273. [PubMed: 18261931]
Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, et al. Depression and cardiac
mortality: results from a community-based longitudinal study. Archives of General Psychiatry
2001;58:221–227. [PubMed: 11231827]
Perreira KM, Sloan FA. Life events and alcohol consumption among mature adults: A longitudinal
analysis. Journal of Studies on Alcohol 2001;62:501–508. [PubMed: 11513228]
Phillips AC, Carroll D, Burns VE, Drayson M. Neuroticism, cortisol reactivity, and antibody response
to vaccination. Psychophysiology 2005;42:232–238. [PubMed: 15787860]
Plomin R, DeFries JC, Loehlin JC. Genotype-environment interaction and correlation in the analysis of
human behavior. Psychological Bulletin 1977;84:309–322. [PubMed: 557211]
Portella MJ, Harmer CJ, Flint J, Cowen P, Goodwin GM. Enhanced early morning salivary cortisol in
neuroticism. American Journal of Psychiatry 2005;162:807–809. [PubMed: 15800161]
Reti IM, Samuels JF, Eaton WW, Bienvenu OJ, Costa PT, Nestadt G. Influences of parenting on normal
NIH-PA Author Manuscript
Science 2007b;2:377–395.
Rutter M. Biological implications of gene-environment interaction. Journal of Abnormal Child
Psychology 2008;36:969–975. [PubMed: 18642072]
Sareen J, Cox BJ, Clara I, Asmundson GJG. The relationship between anxiety disorders and physical
disorders in the U.S. National Comorbidity Survey. Depression and Anxiety 2005;21:193–202.
[PubMed: 16075453]
Saulsman LM, Page AC. The five-factor model and personality disorder empirical literature: A meta-
analytic review. Clinical Psychology Review 2004;23:1055–1085. [PubMed: 14729423]
Schinka JA. Measurement scale does moderate the association between the serotonin transporter gene
and trait anxiety: Comments on Munafo et al. Molecular Psychiatry 2005;10:892–893. [PubMed:
15983622]
Schinka JA, Busch RM, Robichaux-Keene N. A meta-analysis of the association between the serotonin
transporter gene polymorphism (5-HTTLPR) and trait anxiety. Molecular Psychiatry 2004;9:197–
202. [PubMed: 14966478]
Schmutte PS, Ryff CD. Personality and well-being: Reexamining methods and meanings. Journal of
Personality and Social Psychology 1997;73:549–559. [PubMed: 9294901]
Schneiderman N, Ironson G, Siegel SD. Stress and health: Psychological, behavioral, and biological
NIH-PA Author Manuscript
Smith TW, MacKenzie J. Personality and risk of physical illness. Annual Review of Clinical Psychology
2006;2:435–467.
Spijker J, de Graaf R, Oldehinkel AJ, Nolen WA, Ormel J. Are the vulnerability effects of personality
and psychosocial functioning on depression accounted for by subthreshold symptoms? Depression
and Anxiety 2007;24:472–478. [PubMed: 17111387]
Spiller RC. Role of infection in irritable bowel syndrome. Journal of Gastroenterology 2007;42:S41–
S47.
Steel P, Schmidt J, Shultz J. Refining the relationship between personality and subjective well-being.
Psychological Bulletin 2008;134:138–161. [PubMed: 18193998]
Stein MB, Stein DJ. Social anxiety disorder. Lancet 2008;371:1115–1125. [PubMed: 18374843]
Stice E, Rohde P, Seeley JR, Gau JM. Brief cognitive-behavioral depression prevention program for high-
risk adolescents outperforms two alternative interventions: A randomized efficacy trial. Journal of
Consulting and Clinical Psychology 2008;76:595–606. [PubMed: 18665688]
Stronks K, van de Mheen HD, Looman CWN, Mackenbach JP. Cultural, material, and psychosocial
correlates of the socioeconomic gradient in smoking behavior among adults. Preventive Medicine
1997;26:754–766. [PubMed: 9327486]
NIH-PA Author Manuscript
Suarez EC, Lewis JG, Kuhn C. The relation of aggression, hostility, and anger to lipopolysaccharide-
stimulated tumor necrosis factor (TNF)-α by blood monocytes from normal men. Brain, Behavior,
and Immunity 2002;16:675–684.
Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: The problems
and implications of overlapping affective dispositions. Psychological Bulletin 2005;131:260–300.
[PubMed: 15740422]
Suls J, Martin R. The daily life of the garden-variety neurotic: Reactivity, stressor exposure, mood
spillover, and maladaptive coping. Journal of Personality 2005;73:1–25. [PubMed: 15660671]
Tellegen, A. Brief manual for the Multidimensional Personality Questionnaire. Minneapolis: University
of Minnesota; 1982.
ten Have M, Oldehinkel A, Vollebergh W, Ormel J. Does neuroticism explain variations in care service
use for mental health problems in the general population?: Results from the Netherlands Mental
Health Survey and Incidence Study (NEMESIS). Social Psychiatry and Psychiatric Epidemiology
2005;40:425–431. [PubMed: 16003591]
Terracciano A, Costa PT. Smoking and the five-factor model of personality. Addiction 2004;99:472–
481. [PubMed: 15049747]
Trobst KK, Wiggins JS, Costa PT Jr, Herbst JH, McCrae RR, Masters HL. Personality psychology and
problem behaviors: HIV risk and the five-factor model. Journal of Personality 2000;68:1233–1252.
NIH-PA Author Manuscript
[PubMed: 11130739]
Tucker JS, Kressin NR, Spiro A, Ruscio J. Intrapersonal characteristics and the timing of divorce: A
prospective investigation. Journal of Social and Personal Relationships 1998;15:211–225.
Uchino BN. Social support and health: A review of physiological processes potentially underlying links
to disease outcomes. Journal of Behavioral Medicine 2006;29:377–387. [PubMed: 16758315]
Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the
aetiology of mental illness: review and methodological analysis. Molecular Psychiatry
2008;13:131–146. [PubMed: 17700575]
van den Oord EJCG, Kuo PH, Hartmann AM, Webb T, Moller HJ, Hettema JM, et al. Genomewide
association analysis followed by a replication study implicates a novel candidate gene for
neuroticism. Archives of General Psychiatry 2008;65:1062–1071. [PubMed: 18762592]
Van Os J, Jones PB. Neuroticism as a risk factor for schizophrenia. Psychological Medicine
2001;31:1129–1134. [PubMed: 11513380]
van Os J, Park SBG, Jones PB. Neuroticism, life events and mental health: Evidence for person-
environment correlation. British Journal of Psychiatry 2001;178S:s72–s77.
Viken RJ, Rose RJ, Kaprio J, Koskenvuo M. A developmental genetic analysis of adult personality:
extraversion and neuroticism from 18 to 59 years of age. Journal of Personality and Social
Psychology 1994;66:722–730. [PubMed: 8189349]
NIH-PA Author Manuscript
Vogeltanz ND, Hecker JE. The roles of neuroticism and controllability/predictability in physiological
response to aversive stimuli. Personality and Individual Differences 1999;27:599–612.
Watkins LL, Blumenthal JA, Davidson JRT, Babyak MA, McCants CB, Sketch MH. Phobic anxiety,
depression, and risk of ventricular arrhythmias in patients with coronary heart disease.
Psychosomatic Medicine 2006;68:651–656. [PubMed: 17012517]
Watson D, Clark LA, Harkness AR. Structures of personality and their relevance to psychopathology.
Journal of Abnormal Psychology 1994;103:18–31. [PubMed: 8040477]
Watson D, Hubbard B. Adaptational style and dispositional structure: Coping in the context of the five-
factor model. Journal of Personality 1996;64:737–774.
Weinstock LM, Whisman MA. Neuroticism as a common feature of the depressive and anxiety disorders:
A test of the revised integrative hierachical model in a national sample. Journal of Abnormal
Psychology 2006;115:68–74. [PubMed: 16492097]
Weiss A, Bates TC, Luciano M. Happiness is a personal(ity) thing: The genetics of personality and well-
being in a representative sample. Psychological Science 2008;19:205–210. [PubMed: 18315789]
Weiss A, Costa PT. Domain and facet personality predictors of all-cause mortality among medicare
patients aged 65 to 100. Psychosomatic Medicine 2005;67:724–733. [PubMed: 16204430]
Widiger TA, Trull TJ. Plate tectonics in the classification of personality disorder - Shifting to a
NIH-PA Author Manuscript
Table 1
Cohen’s d effect sizes for associations between neuroticism and Axis I mental disorders from the meta-analysis by Malouff et al. (2005).
Lahey
Mood Disorders Anxiety Disorders Somatoform Disorders Alcohol and Drug Disorders Schizophrenia Eating Disorders
1.54 1.04 1.20 .54 1.08 1.29
Note: For effect sizes expressed as Cohen’s d. d > .50 = “moderate effect”; d > 1.0 = “large effect.” All associations are significant at p < .0001.
Table 2
Cohen’s d effect sizes for magnitudes of associations between neuroticism and Axis II personality disorders from the meta-analysis conducted by Saulsman
and Page (2004)
Lahey
Note: Cohen’s d > .50 = “moderate effect”, d > 1.0 = “large effect.” All associations p < .0001, except for narcissitic personality disorder which was not significant at p < .05.